Main competitors
Add to a list
1m. Revenue rev. 4m. EPS revision 4m. Revenue rev. 1y. EPS revision 1y. Revenue rev. Visibility Nbr of analysts
6
26
24
21
27
19
24
20
19
26
22
22
25
21
19
15
18
17
17
Average 20
Weighted average by Cap. 23
Other Pharmaceuticals